BERWYN, PA — AscellaHealth has been named to the Financial Times’ list of the Americas’ Fastest Growing Companies 2026, marking its fourth consecutive year on the ranking.
The list, compiled with data provider Statista, recognizes companies with the highest revenue growth between 2021 and 2024 among independent firms headquartered in the Americas.
To qualify, companies must report revenue of at least $100,000 in 2021 and $1.5 million in 2024 and demonstrate primarily organic growth.
The ranking was published April 2, 2026, and is available at https://www.ft.com/content/3d3b5406-b7e6-4ef0-8b50-cf02904589cb?syn-25a6b1a6=1.
Chief Executive Officer Dea Belazi said the recognition reflects the company’s expansion and focus on patient access to therapies.
“Our momentum is driven by a clear purpose—to transform the lives of patients and their families—while scaling globally,” Belazi said.
Chairman and President Bill Oldham said the company’s growth is tied to its operating strategy and global expansion.
“With operations spanning more than 70 countries, we remain focused on scaling responsibly and sustainably,” Oldham said.
AscellaHealth provides services across the specialty pharmaceutical supply chain, including product access, commercialization, and patient support.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.